Cryosite Ltd
ASX:CTE

Watchlist Manager
Cryosite Ltd Logo
Cryosite Ltd
ASX:CTE
Watchlist
Price: 1.05 AUD
Market Cap: AU$51.3m

CTE's latest stock split occurred on Apr 29, 2004

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

The adjusted shares began trading on Apr 29, 2004. This was the only stock split in CTE's history.

Last Splits:
Apr 29, 2004
1-for-1
Pre-Split Price
N/A
Post-Split Price
0.1468
Before
After
Last Splits:
Apr 29, 2004
1-for-1

Cryosite Ltd
Stock Splits History

CTE Stock Splits Timeline
Apr 29, 2004
Apr 29, 2004
Split 1-for-1
/1
Pre-Split Price
N/A
Post-Split Price
0.1468
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 22, 2026
Chimeric Therapeutics Ltd
ASX:CHM
1-for-100
/100
0.002 0.2 AUD 0.17 0.17 AUD
Apr 22, 2026
Architects Studio Japan Inc
TSE:6085
10-for-1
x10
3800 380 JPY 430 430 JPY
Apr 22, 2026
Freewon China Co Ltd
SSE:688678
1-for-1
x1
30.5 21.6857 CNY 23.64 23.64 CNY
Apr 22, 2026
S
Sharetronic Data Technology Co Ltd
SZSE:300857
1-for-1
x1
304.5701 217.2101 CNY 260.76 260.76 CNY
Apr 21, 2026
Canon Electronics Inc
OTC:CAOEF
1-for-6235122
/6235122
16.96 16.96 USD N/A
Load More

Cryosite Ltd
Glance View

Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.

CTE Intrinsic Value
0.86 AUD
Overvaluation 18%
Intrinsic Value
Price AU$1.05
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett